Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03347058 · ClinicalTrials.gov registry record · NA
Immunotherapy & Me
A NA study, sponsored by Cancer Support Community, Research and Training Institute, Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT03347058 is a NA study that has completed, run by Cancer Support Community, Research and Training Institute, Philadelphia. The registered enrollment target is 134 participants.
The verdict
NCT03347058, a NA study, has completed, sponsored by Cancer Support Community, Research and Training Institute, Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
Immunotherapy \& Me is a pilot study to determine patient and provider needs around immunotherapy treatment, and to determine the most meaningful resources to improve patient outcomes and decrease cost. Specifically, this study aims: 1. To determine whether layering in customizable resources at the point-of-care that offer healthcare providers care-management tools to give their immunotherapy patients leads to changes in (a) patients' knowledge, attitudes, and health behaviors (including self-reported measures of self-efficacy and empowerment, cancer-related distress, quality of life, and satisfaction with the programs offered) and (b) improved clinical outcomes (including decreased hospital admissions, decreased hospital readmissions, and decreased costs associated with hospitalizations). 2. To successfully integrate the Immunotherapy \& Me program within oncology practices to provide a model framework for dissemination across other care providers. Once success is demonstrated, a turn-key model of immunotherapy patient support can be expanded to other oncology care systems.
Interventions
- OTHER Supportive programming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2021-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03347058
The ClinicalTrials.gov registry entry for NCT03347058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cancer Support Community, Research and Training Institute, Philadelphia, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Supportive programming is the first listed.
NCT03347058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03347058 about?
NCT03347058 is a clinical study titled "Immunotherapy & Me". Immunotherapy \& Me is a pilot study to determine patient and provider needs around immunotherapy treatment, and to determine the most meaningful resources to improve patient outcomes and decrease cost. Specifically, this study aims: 1. To determine whether layering in customizable resources at the...
What is the current status of trial NCT03347058?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2017-12-01. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT03347058?
The interventions under investigation include: Supportive programming (OTHER).
Who is sponsoring clinical trial NCT03347058?
This trial is sponsored by Cancer Support Community, Research and Training Institute, Philadelphia, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.